With TIGIT-CD226 co-expression mainly seen in JIA SF Tregs, this receptor-receptor interaction will likely alter Treg signalling, behaviour and functional outcome at the site of inflammation, while in healthy control blood Tregs the direct effects of TIGIT or CD226 predominate. This evidence concerns the gene CD226 and juvenile idiopathic arthritis.